Big Tobacco’s Investments in and Acquisitions of Pharmaceutical Companies

October 05, 2021

Recently there have been several instances of tobacco companies acquiring or attempting to acquire pharmaceutical and related companies, a problematic pairing. The entry of Big Tobacco into medicine opens the door for corporate social responsibility opportunities and may give the industry friendly inroads to governments.

Read the brief to learn more about this pressing concern and how governments can resist tobacco interference in public health.

Big Tobacco’s Investments in and Acquisitions of Pharmaceutical Companies